Why TGTX Stock Is Rallying Today - Yahoo Finance

18 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

9%
OFF

Why TGTX Stock Is Rallying Today - Yahoo Finance

2 weeks from now

18 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

yahoo.com

7%
OFF

TG Therapeutics Shares Climb 7% As Sales Grow For ... - MarketWatch

2 weeks from now

Shares of TG Therapeutics rose after the company raised its guidance on better-than-expected sales of its multiple sclerosis drug. Shares were up 7.7% Tuesday to $29.79. The stock is …

marketwatch.com

5%
OFF

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

2 weeks from now

14 hours ago · TG Therapeutics (TGTX Quick Quote TGTX - Free Report) shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher …

zacks.com

30%
OFF

TG Therapeutics Stock Just Rallied 30%: What Happened? - MSN

2 weeks from now

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. Why is TG Therapeutics stock up …

msn.com

$1.33
OFF

TG Therapeutics (TGTX) Upgraded To Buy: What Does It Mean For …

2 weeks from now

Jan 9, 2023 · Earnings Estimate Revisions for TG Therapeutics This biopharmaceutical company is expected to earn -$1.33 per share for the fiscal year ending December 2022, which …

nasdaq.com

18%
OFF

What's Going On With TG Therapeutics Stock? - Benzinga

2 weeks from now

Jan 9, 2024 · TG Therapeutics, Inc. (NASDAQ: TGTX) shares are trading lower Tuesday, though the stock remains up 18% over the past five days. Here's a look at what's going on.

benzinga.com

18%
OFF

Why Shares Of TG Therapeutics Soared On Tuesday - Sharewise

2 weeks from now

Apr 11, 2023 · Shares of TG Therapeutics (NASDAQ: TGTX) were up by 18% as of mid-afternoon Tuesday after reports that the biotech's multiple sclerosis therapy Briumvi would have better …

sharewise.com

5%
OFF

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength …

2 weeks from now

TG Therapeutics TGTX shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher-than-average number of shares changing hands …

msn.com

865%
OFF

TG Therapeutics: Briumvi Revenue Soars - The Motley Fool

2 weeks from now

Nov 5, 2024 · Why Shares of TG Therapeutics Soared on Tuesday. 865%. Premium Investing Services. Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, …

fool.com

40%
OFF

Why TG Therapeutics Is Plunging More Than 40% Today

2 weeks from now

Nov 30, 2021 · What happened. Shares of biopharma outfit TG Therapeutics (NASDAQ: TGTX) are down to the tune of 43.4% as of 11:38 a.m. ET Tuesday after the company announced the …

nasdaq.com

4%
OFF

TG Therapeutics (NASDAQ:TGTX) Trading Down 2.4% - Here's Why …

2 weeks from now

Dec 31, 2024 · TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report)'s share price fell 2.4% on Tuesday . The company traded as low as $30.61 and last traded at $30.68. 366,002 shares …

marketbeat.com

4%
OFF

Why TG Therapeutics Stock Is Crashing Today | The Motley Fool

2 weeks from now

Aug 1, 2023 · What happened. Shares of TG Therapeutics were crashing 50.4% lower as of 11:12 a.m. ET on Tuesday. The huge sell-off came after the company announced its second-quarter …

fool.com

FAQs about Why TGTX Stock Is Rallying Today - Yahoo Finance Coupon?

Why did TG Therapeutics stock rise?

By Owen Tucker-Smith Shares of TG Therapeutics rose after the company raised its guidance on better-than-expected sales of its multiple sclerosis drug. Shares were up 7.7% Tuesday to $29.79. The stock is about 18% below its 52-week high of $36.84. ...

Why are TG Therapeutics (tgtx) shares climbing 9% today?

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. Briumvi's 2024 Revenue Exceeded TG's Guidance The company estimated today that its 2024 revenue from the MS treatment had come in at $310 million. ...

Why is TG Therapeutics stock up 30% on Wednesday?

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. Why is TG Therapeutics stock up today? The biotech stock is being rewarded primarily because the revenue printed at $63.47 million versus analysts at $54.61 million. ...

Is TG Therapeutics stock down 15% versus its year-to-date high?

TG Therapeutics stock is still down 15% versus its year-to-date high. Note that TG Therapeutics lost 7 cents a share in its first financial quarter which was worse than 4 cents a share that experts had forecast. ...

Does TG Therapeutics stock pay a dividend?

In January, $TGTX acquire a worldwide license for Azer-cel as Invezz reported here. Wall Street currently has a consensus “overweight” rating on TG Therapeutics shares that do not pay a dividend at writing. The post TG Therapeutics stock just rallied 30%: what happened? appeared first on Invezz ...

Is TG Therapeutics (tgtx) a good stock to buy?

Commercial-stage biotech TG Therapeutics ( TGTX -1.77%) was having a fine week on the stock exchange, thanks in no small part to an investor-pleasing earnings report. It unveiled its first-quarter fundamentals on Wednesday, and was quite the hot item in subsequent days. ...